QCIL
About QCIL
Quality Chemical Industries Limited (QCIL), formerly Cipla Quality Chemical Industries Limited (CiplaQCIL) is a pharmaceutical manufacturing company, established in Uganda in 2005. The company is the largest producer of World Health Organization (WHO) pre-qualified HIV/AIDS and malaria treatments in the region. According to a 2007 published report, QCIL was the only company in Africa to manufacture triple-combination antiretroviral (ARV) drugs. QCIL currently produces TLD, the latest first-line treatment used to treat and prevent HIV/AIDS. QCIL also manufactures antimalarials (ACTs), including Lumartem, containing artemisinin and lumefantrine, and the Hepatitis B generic medicines Texavir and Zentair.
From Wikipedia: Quality Chemical Industries Limited ↗ · CC BY-SA 4.0. We match articles conservatively; if this looks like the wrong company, it is a bug worth reporting.
- Listing
- QCIL trades as USE:QCIL on the Uganda Securities Exchange in Kampala, Uganda.
- Trading
- Quoted and settled in UGX, and the market is open 09:00–13:00 EAT. One share is currently about $0.0391.
- Liquidity
- 0 shares changed hands in the last session — thin enough that a modest order could move the price, and that exiting may take time. Why liquidity matters here
- Range
- Over the period we hold, it has traded between 160.00 and 161.88 UGX. Today's price sits 100% of the way up that range.
- Access
- Most international brokers do not reach USE. Getting in usually means a local or diaspora account, and getting money out is a separate question from getting in. How to buy shares on the USE →
Chart
recorded daily by us2026-09-30161.88 UGXVol 12.8K
7 closing prices we recorded ourselves, 9 Aug 2026 to . None of our sources supplies a history for this market. Two things follow from that. These are raw closes, so a share split shows as a fall rather than being adjusted away. And where the exchange publishes no session date — BRVM and Uganda do not — a point is dated when we OBSERVED the price, not when it traded, and is only recorded when the price actually moved.
Performance
local currency, to 12 Oct 2026- 1 week
- 0.0%
- 4 weeks
- +1.2%
- 3 months
- —
- 6 months
- —
- 1 year
- —
- YTD
- —
Computed by us from the closing prices we have recorded since 9 Aug 2026. A period that record does not yet cover, or that spans a jump in price or a change in the number of shares, is left blank rather than estimated.
Key figures
- Volume
- 0
ISIN, Board, Day range, 52-week range, Turnover, Market cap, Shares outstanding, P/E ratio, EPS and Dividend / share are not published by USE. Dividend yield is a figure we work out ourselves, and we do not hold enough verified data to compute it for this listing. What each source covers
Price history
weekly closes · showing 7 of 7| Date | Close | Volume |
|---|---|---|
| 30 Sept 2026 | 161.88 | 12,842 |
| 17 Sept 2026 | 161.00 | 269,800 |
| 14 Sept 2026 | 160.00 | 100 |
| 12 Sept 2026 | 161.00 | 44,200 |
| 2 Sept 2026 | 160.00 | 4,000 |
| 31 Aug 2026 | 160.77 | 0 |
| 9 Aug 2026 | 160.00 | 45,100 |
Questions
- What is the QCIL share price today?
- QCIL (USE) was at UGX 161.88 in Djeli's update of 12 Oct 2026. Its source does not give the date of the session it comes from.
- Where is QCIL listed?
- QCIL is listed on the Uganda Securities Exchange (USE) in Uganda, and trades in UGX.
- When is QCIL's next announced date?
- We hold no announced future date for QCIL. Dates projected from past payments are not counted as announced.
- How has QCIL performed over the past four weeks?
- QCIL returned +1.2% in UGX over the past four weeks, to 12 Oct 2026.
Events
No dividend or split on record for QCIL
We hold verified corporate actions for companies whose ex-dividend records we could read; this one has none on file. It does not mean none happened. What we do hold